A 48-week antiviral efficacy of combination therapy of Shuanghu Qinggan Keli and entecavir tablets on HBeAg-positive patients with chronic hepatitis B

LI Feng-yi; ZHAO Min; LI Wen-gang; TU Bo; ZHANG Xin; NIE Wei-min

doi:10.3969/j.issn.1007-8134.2012.04.013

Home>Articles>A 48-week antiviral efficacy of combination therapy of Shuanghu Qinggan Keli and entecavir tablets on HBeAg-positive patients with chronic hepatitis B

DOI: 10.3969/j.issn.1007-8134.2012.04.013

A 48-week antiviral efficacy of combination therapy of Shuanghu Qinggan Keli and entecavir tablets on HBeAg-positive patients with chronic hepatitis B

LI Feng-yi

ZHAO Min

LI Wen-gang

TU Bo

ZHANG Xin

NIE Wei-min

Machine-generated Keywords：

Publication Date：2012-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 232-234 )

INFECTIOUS DISEASE INFORMATION

ISTIC

ISSN：1007-8134

Year, Vol.(Issue)：2012,25(4)